User login
Key clinical point: This meta-analysis found no significant association between multiple sclerosis and vitiligo.
Major finding: No significant association of multiple sclerosis with prevalent vitiligo was found (pooled odds ratio, 1.33; 95% confidence interval, 0.80-2.22).
Study details: A meta-analysis of 6 case-control studies including 12,930 participants.
Disclosures: No study sponsor was identified. The authors declared no conflicts of interest.
Source: Shen MH et al. Sci Rep. 2020 Oct 20. doi: 10.1038/s41598-020-74298-0.
Key clinical point: This meta-analysis found no significant association between multiple sclerosis and vitiligo.
Major finding: No significant association of multiple sclerosis with prevalent vitiligo was found (pooled odds ratio, 1.33; 95% confidence interval, 0.80-2.22).
Study details: A meta-analysis of 6 case-control studies including 12,930 participants.
Disclosures: No study sponsor was identified. The authors declared no conflicts of interest.
Source: Shen MH et al. Sci Rep. 2020 Oct 20. doi: 10.1038/s41598-020-74298-0.
Key clinical point: This meta-analysis found no significant association between multiple sclerosis and vitiligo.
Major finding: No significant association of multiple sclerosis with prevalent vitiligo was found (pooled odds ratio, 1.33; 95% confidence interval, 0.80-2.22).
Study details: A meta-analysis of 6 case-control studies including 12,930 participants.
Disclosures: No study sponsor was identified. The authors declared no conflicts of interest.
Source: Shen MH et al. Sci Rep. 2020 Oct 20. doi: 10.1038/s41598-020-74298-0.